Growth Metrics

Organogenesis Holdings (ORGO) Consolidated Net Income: 2017-2025

Historic Consolidated Net Income for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Consolidated Net Income rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 31.63%. This contributed to the annual value of -$9.9 million for FY2024, which is 299.35% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Consolidated Net Income stood at $21.6 million, which was up 329.63% from -$9.4 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Consolidated Net Income high stood at $51.0 million for Q4 2021, and its period low was -$18.8 million during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Consolidated Net Income value was -$2.1 million (recorded in 2024), while the average stood at -$1.1 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Consolidated Net Income spiked by 1,373.02% in 2023, and later tumbled by 797.29% in 2025.
  • Organogenesis Holdings' Consolidated Net Income (Quarterly) stood at $51.0 million in 2021, then plummeted by 85.32% to $7.5 million in 2022, then slumped by 107.59% to -$568,000 in 2023, then plummeted by 436.27% to -$3.0 million in 2024, then spiked by 74.90% to $21.6 million in 2025.
  • Its Consolidated Net Income stands at $21.6 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$18.8 million for Q1 2025.